| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $272K | -47.6% |
| Operating Income | -$272K | +53.4% |
| Interest Expense | $40K | — |
| Net Income | -$314K | +54.8% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15K | -42.8% |
| Current Assets | $18K | -41.3% |
| Total Assets | $18K | -41.3% |
| Current Liabilities | $2.5M | +0.1% |
| Stockholders' Equity | -$2.5M | -0.7% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$171K | +29.9% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $160K | +481.6% |